On this episode, Hall welcomes Jay Olshansky, Co-Founder and Chief Scientist of Lapetus Solutions. Lapetus Solutions, Inc. (LSI) is a science and technology growth company dedicated to creating products and services that will revolutionize the prediction of life events. By combining biodemography, dynamic questioning, and facial analytics, while harnessing the power of cloud computing, their scientific approach delivers faster, more accurate results in real-time.
For the last 20 years, Jay has been a professor of public health in Illinois. Before that, he spent a decade in internal medicine at the University of Chicago. His focus for the last 35 years has been estimating the duration of life. In this episode, Jay shares how he started Lapetus Solutions. An expert in his field, Jay was approached by the late Bob Benmosche, who was the CEO of AIG at the time. Bob expressed that the insurance world has no knowledge of technology on the topic and hoped it would help them to operate more efficiently. Shortly after, Jay began looking for a colleague who could help address an issue in the field- the fact that the children of long-lived people tend to look young for their age. In other words, they’re aging at a slower rate. Jay was looking for another scientist that could help measure that. That’s what led him to co-founder Dr. Karl Ricanek, a pioneer in the field of facial analytics, and the two created a company as a result.
You can find Lapetus Solutions at lapetussolutions.com/
Jay can be reached on LinkedIn at linkedin.com/in/s-jay-olshansky-ph-d-2b67643/
Copyright (c) 2021, Hall Martin and investorconnect.org. All rights reserved.
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.